American Association for the Advancement of Science, Science Translational Medicine, 584(13), 2021
DOI: 10.1126/scitranslmed.aay9056
Full text: Unavailable
In situ genome targeting of Na V 1.7 via CRISPRs and zinc fingers enables genomically scarless, durable, and nonaddictive management of pain.